International Radiosurgery Research Foundation is located in Pittsburgh, PA. The organization was established in 2010. According to its NTEE Classification (H30) the organization is classified as: Cancer Research, under the broad grouping of Medical Research and related organizations. This organization is an independent organization and not affiliated with a larger national or regional group of organizations. International Radiosurgery Research Foundation is a 501(c)(3) and as such, is described as a "Charitable or Religous organization or a private foundation" by the IRS.
For the year ending 12/2023, International Radiosurgery Research Foundation generated $91.7k in total revenue. This represents a relatively dramatic decline in revenue. Over the past 8 years, the organization has seen revenues fall by an average of (10.8%) each year. All expenses for the organization totaled $50.8k during the year ending 12/2023. You can explore the organizations financials more deeply in the financial statements section below.
Form
990PF
Mission & Program ActivityExcerpts From the 990PF Filing
TAX YEAR
2023
Describe the Organization's Program Activity:
Part 3 - Line 4a
2 PROSPECTIVE CLINICAL TRIALS IN PROCESS - PROGRESS PROGRAM EXPENSES CONSIST OF PAYMENTS TO MEMBER HOSPITALS AND RESEARCH CENTERS THROUGH CONTRACTUAL RELATIONSHIPS, BASED ON RESEARCH PROPOSALS AND RELATED BUDGETS, TO CONDUCT SPECIFIC PROSPECTIVE CLINICAL TRIALS TO FURTHER THE ORGANIZATION'S MISSION. INTERIM AND FINAL RESEARCH REPORTS ARE PROVIDED TO THE ORGANIZATION AS THE TRIALS PROGRESS. PAYMENT IS MADE AS RESEARCH PROGRESSES AND AS OUTLINED IN THE CONTRACT. CONTRACTS ARE OCCASIONALLY AMENDED, AND PAYMENTS DELAYED, IF TIMING OF THE RESEARCH, AND THE RELATED RESULTS ARE DELAYED CURRENTLY 1 STUDY IN PROCESS - RESEARCHER MIAMI BAPTIST HOSPITAL
IRRF STUDIES APPROVED IN 2023 PIIRRF MEMBERIRRF CENTERSTUDY TITLE 1YAVUZ SAMANCISELCUK PEKERKOC UNIVERSITY BRAIN METASTASIS FROM CHOLANGIOCARCINOMA 2YAVUZ SAMANCISELCUK PEKERKOC UNIVERSITY RADIOSURGERY FOR PLEOMORPHIC XANTHOASTROCYTOMA 3AHMED SHAABANSHEEHANUVASTEREOTACTIC RADIOSURGERY FOR HEMANGIOBLASTOMA 4TIMOTEO ALMEIDACAROLINA BENJAMINUMIAMIASSESSING OUTCOMES AFTER SRS IN PATIENTS WITH TUMOR-RELATED TN 5CHING-JEN CHENCHING-JEN CHENUTEXASPROPOSAL FOR IRRF AND CONDOR LOW-GRADE DAVFS PROJECT 6RAJ SINGHSHEEHANUVADOSIMETRIC PREDICTORS OF TOXICITY FOR BRAINSTEM LESIONS 7TANXIA QUKONDZIOLKANYUCALCULATE DOSE RATE FROM THE "SEALED SOURCE TEST CERTIFICATE": 8RAJ SINGHSHEEHANUVABRAIN METASTASES FROM SARCOMA PRIMARIES 9FERNANDO SHEEHANUVASAFETY AND EFFICACY OF A THIRD SRS FOR RECURRENT TRIGEMINAL NEURALGIA 10SAMLUNSFORDUPMCSRS FOR PITUITARY METASTASES 2023 IRRF PUBLICATIONS 1-20 1.ABOU-AL-SHAAR H, PATEL A, MALLELA AN, ET AL. CHRONIC ENCAPSULATED EXPANDING HEMATOMAS AFTER STEREOTACTIC RADIOSURGE
Name (title) | Role | Hours | Compensation |
---|---|---|---|
Douglas Kondziolka MD Director | 0 | $0 | |
John Suh MD Secretary/tr | 1 | $0 | |
Anthony Kaufman MD Director | 0 | $0 | |
L Dade Lunsford MD Director | 0 | $0 | |
David Mathieu MD Director | 0 | $0 | |
Rafael Rodriguez Mercado MD Director | 0 | $0 |
Statement of Revenue | |
---|---|
Contributions, Gifts, Grants & Similar | $91,250 |
Interest on Savings | $484 |
Dividends & Interest | $0 |
Net Rental Income | $0 |
Net Gain on Sale of Assets | $0 |
Capital Gain Net Income | $0 |
Net ST Capital Gain | $0 |
Income Modifications | $0 |
Profit on Inventory Sales | $0 |
Other Income | $0 |
Total Revenue | $91,734 |
Statement of Expenses | |
---|---|
Compensation of officers, directors, trustees, etc | $0 |
Other employee salaries and wages | $0 |
Pension plans, employee benefits | $0 |
Interest | $0 |
Taxes | $100 |
Depreciation | $0 |
Occupancy | $0 |
Travel, conferences, and meetings | $2,221 |
Printing and publications | $5,005 |
Other expenses | $7,427 |
Total operating and administrative expenses | $50,833 |
Contributions, gifts, grants paid | $0 |
Total expenses and disbursements | $50,833 |
Balance Sheet | |
---|---|
Cash—non-interest-bearing | $748,267 |
Savings and temporary cash investments | $0 |
Net Accounts receivable | $88,000 |
Net Pledges Receivable | $0 |
Grants receivable | $0 |
Receivables from Officers, Directors, or Controlling Persons | $0 |
Net other notes and loans receivable | $0 |
Inventories for sale or use | $0 |
Prepaid expenses and deferred charges | $0 |
Net Investments - land, buildings, equipment | $0 |
Investments—mortgage loans | $0 |
Investments—other | $0 |
Net Land, buildings, and equipment | $0 |
Other assets | $88 |
Total assets | $836,355 |
Accounts payable and accrued expenses | $24,053 |
Grants payable | $0 |
Deferred revenue | $5,000 |
Loans and other payables to any current Officer, Director, or Controlling Person | $0 |
Mortgages and other notes payable | $0 |
Other liabilities | $0 |
Total liabilities | $29,053 |
Over the last fiscal year, International Radiosurgery Research Foundation has awarded $40,407 in support to 2 organizations.
Grant Recipient | Amount |
---|---|
UNIVERSITY OF PITTSBURGH PURPOSE: PROSPECTIVE CLINICAL TRIAL | $30,000 |
TORONTO WESTERN HOSPITAL PURPOSE: CLINICAL TRIAL EXPENSE REIMB | $10,407 |